Tci Wealth Advisors, Inc. Myriad Genetics Inc Transaction History

Tci Wealth Advisors, Inc.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	SELL	$14.51 - $20.99 $2,568 - $3,715	-177 Reduced 65.07%	95 $1,000
Q3 2022 Nov 08, 2022	BUY	$18.21 - $27.88 $54 - $83	3 Added 1.12%	272 $5,000
Q2 2022 Jul 19, 2022	SELL	$16.45 - $25.88 $1,447 - $2,277	-88 Reduced 24.65%	269 $5,000
Q1 2022 Apr 29, 2022	BUY	$22.67 - $28.01 $6,007 - $7,422	265 Added 288.04%	357 $9,000
Q4 2021 Jan 24, 2022	SELL	$24.13 - $32.63 $4,053 - $5,481	-168 Reduced 64.62%	92 $3,000
Q3 2021 Oct 29, 2021	BUY	$29.97 - $36.66 $2,667 - $3,262	89 Added 52.05%	260 $8,000
Q2 2021 Aug 02, 2021	SELL	$25.39 - $32.61 $177 - $228	-7 Reduced 3.93%	171 $5,000
Q1 2021 Apr 29, 2021	BUY	$19.92 - $31.6 $1,713 - $2,717	86 Added 93.48%	178 $5,000
Q1 2020 Apr 14, 2020	BUY	$9.78 - $29.53 $645 - $1,948	66 Added 253.85%	92 $1,000
Q2 2019 Jul 23, 2019	SELL	$22.67 - $35.0 $1,133 - $1,750	-50 Reduced 65.79%	26 $1,000
Q4 2018 Jan 17, 2019	BUY	$27.23 - $45.56 $1,388 - $2,323	51 Added 204.0%	76 $2,000
Q2 2018 Jul 27, 2018	SELL	$27.75 - $40.17 $444 - $642	-16 Reduced 39.02%	25 $1,000
Q1 2018 Apr 30, 2018	BUY	$28.83 - $41.01 $634 - $902	22 Added 115.79%	41 $1,000
Q3 2017 Oct 24, 2017	BUY	$24.01 - $36.2 $456 - $687	19	19 $1,000

253

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.22B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.